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The objective of this study was to evaluate the estrogenic and anti-estrogenic actions, as well as the 
reproductive and foetal toxicity, of the ethanol extract from Copaifera luetzelburgii (EEtOH-Cl). In the 
experiment of (anti) estrogenicity, nulliparous Wistar rats were treated for 3 days with EEtOH-Cl (125, 
250 and 500 mg/kg); estradiol (E, 5 μg/kg); E + EEtOH-Cl; tamoxifen (T, 4mg/kg). This extract presented 
estrogenic activity by increasing the relative weight (%) of the uterus of rats treated at doses of 125, 250 
and 500 mg/kg (0.267 ± 0.016*, 0.231 ± 0.014*, 0.242 ± 0.015*), and it showed anti-estrogenic activity 
when associated with estradiol (0.116 ± 0.006*, 0.103 ± 0.06*, 0.098 ± 0.05*), respectively. For 
assessment of toxicity in pregnancy, the animals were divided into two groups and treated daily with 
EEtOH-Cl. In the first group, the effect of the extract on the development of pregnancy from first to 
seventh day was observed, and in the second group, from 8 to 21 days, there was no change of these 
parameters or the viability of the progeny when the study assessed reproductive and foetal toxicity; 
however, there was shortening of pregnancy (125 mg/kg) without affecting the progeny. In the in vitro 
study, uterine strips of pregnant (P) and non-pregnant (NP) females were used. In both groups, half 
received EEtOH-Cl (vo) for 13 days (treated females - T), and the other half received EEtOH-Cl directly to 
the isolated organ bath system (untreated - NT). In vitro study on the uterus of pregnant animals 
pretreated with doses of 250 and 500 mg/kg showed that there was inhibition of KCl 80-induced phasic 
contractions (0.490 ± 0.110, 0.540 ± 0.092), respectively. Also, the contractions induced by oxytocin 
were inhibited at a dose of 500 mg/kg (0.380 ± 0.109). In non-pregnant, non-treated females, the extract 
at a concentration of 125 µg/mL (0.180 ± 0.062) also inhibited the contractions induced by oxytocin. 
Thus, EEtOH-Cl demonstrated estrogenic activity, but when combined with estradiol, it demonstrated 
anti-estrogenic activity. It did not induce toxicity in the progenitors or in the progeny, and it inhibited 
isometric contractions induced by oxytocin and KCl 80 mM in pregnant and non-pregnant rats.  
 





The use of medicinal plants for treatment, cure and pre-
vention of diseases has been described by many people 
since ancient times. Because of this use, scientific and 
commercial interests have emerged, and therefore it has 
become necessary to evaluate the efficacy and safety of 





absence of chemical products, products that can be dan-
gerous. This concept is misleading, however, since many 
plants themselves contain substances with toxic action 
on living organisms (Lourenço et al., 2009).  
During pregnancy, the use of any medication should be 
done carefully because some toxic substances can cross 
the hematoplacental barrier and interfere with embryo-
foetal development, often in a negative way (Oestensen 
et al., 2006). Thus, according to the study of Lourenço et 
al. (2009), the same caution should apply to the use of 
medicinal plants, mainly due to lack of information about 
them. 
A plant that has been recently attracting scientific 
interest because of the multiple therapeutic properties 
attributed to it is ‘copaibeira’. It is a tree of the Caesalpiniaceae 
family, genus Copaifera L-1762 - also popularly known as 
amaranth, copaiba, ‘copiuba’, ‘pau-de-óleo’ and ‘jatobá–
merim’ - which produces an oleo-resin known as ‘bálsamo’, 
whose physicochemical and organoleptic characteristics 
tend to vary depending on the species. There are more 
than 100 species described for the genus Copaifera, with 
some named C. officinalis, C. langsdorffii, C. glabra, C. 
multijuga and C. luetzelburgii (Vieira, 1992; Brito et al., 2005).  
The properties attributed to copaiba are anti-inflam-
matory, analgesic, antibacterial, astringent, healing, emo-
llient, diuretic, expectorant, laxative, anticarcinogenic and 
abortive, among others, although there is still no scientific 
proof for most of them (Brito, 1995). Among the various 
properties of the oil from copaiba that have already been 
studied are anti-inflammatory (Basilie et al., 1988), anal-
gesic (Fernandes et al., 1992), antitumor (Ohsaki et al., 
1994), acute cytotoxicity and toxicity (Moura et al., 2010), 
and insecticidal activity (Alves et al., 2012). 
However, according to the State Program for Medicinal 
Plants of the State Health Secretariat of Rio de Janeiro, 
some genera like Copaifera L. enter the list of medicinal 
plants contraindicated in pregnancy or lactation, with no 
certainty that they induce abortion or teratogenicity 
(Soares et al., 2003). The ability to induce abortion for 
most plants is attributed to possible estrogenic, cytotoxic 
and/or stimulant activities of uterine contractility (Montanari, 
2008). In several articles about medicinal plants, copaiba 
is cited as being oxytocic and cathartic, but scientific 
studies have demonstrated its anti-spasmodic and rela-
xing effect on smooth muscle of the stomach (Cunha et 
al., 2003). Another important factor is that most of the 
studies so far have used only the oil, which has had the 
most popular use, leaving open the possibility of studies 
with other plant parts such as the bark, leaves and fruit. 
Within this perspective, the objective of this study was to 
evaluate the estrogenic and anti-estrogenic actions as 
well as the reproductive and foetal toxicities of the 
ethanol extract from Copaifera luetzelburgii. 










The Wistar rats used in this study were kept in cages at a controlled 
temperature (24 ± 1°C) and 12 h light/dark cycle, with free access 
to food and water. Following the experimental procedures, the 
animals were euthanized by cervical dislocation. Experimental 
protocols were approved by the Ethics Committee for Animal 




Chemicals and drugs 
 
All reagents were of high quality and obtained from accredited 
suppliers: tamoxifen (DEG, China); estradiol cypionate (ECP), KCl 
and oxytocin (Sigma, USA). 
 
 
Preparation of the ethanol extract of Copaifera luetzelburgii 
 
The collection of the stem bark of Copaifera luetzelburgii was 
procurec in February of 2008 and 2009 from the community of 
‘Quilombola dos Macacos’, near the municipality of ‘São Miguel do 
Tapuio’ (5°30'14" S, 41°19'22" W), Piauí State, Brazil, and identified 
by Professor Dr. Ana Luísa Du Bocage Neta. A voucher specimen 
was deposited under No. 26.235 in the Graziela Barroso 
Herbarium, Federal University of Piauí, Teresina, Piauí. 
The bark of the plant was cut and dried in a forced-air circulation 
oven for three days at a maximum temperature of 45°± 1°C. Then, 
this material was triturated in a laboratory knife mill, type Willy. The 
extract was prepared by placing 1000 g of the plant material in 
ethanol 99.5% for four days at ambient temperature. This was 
subjected to a process of cold maceration, followed by filtration. 
After four successive extractions, it was placed in a rotary 
evaporator coupled with a thermostat set to 45°C for removal of the 





In this test, 100 nulliparous Wistar rats used (21 ± 1 day, postnatal), 
were divided into groups of 10 animals and treated for three 
consecutive days (once daily). For the tests of estrogenicity, the 
animals received the ethanol extract of Copaifera luetzelburgii 
(EEtOH-Cl) at doses of 125, 250 and 500 mg/kg (per orally (p.o.); 
estradiol (E) 5 μg/kg (i.p.) was positive control. For the estimation of 
anti-estrogenic activity, the following treatments were performed: 
E+EEtOH-Cl 125 mg/kg; E+EEtOH-Cl 250 mg/kg; E+EEtOH-Cl 500 
mg/kg; tamoxifen (T) 4 mg/kg (p.o.); and Tamoxifen + Estradiol 
(positive controls). The negative control was performed with distilled 
water at 1 ml 100 g (p.o.) + corn oil 0.05 ml/animal (i.p). In the 
treatments with the combination of substances, the second sub-
stance was administered immediately after the first. After three days 
of treatments, the animals had their body weights measured and 
then were euthanized by cervical dislocation. The uterus and 
ovaries were removed by cutting just below the connection with the 
cervix and above the ovaries. After discarding the liquid present
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Figure 1. EEtOH-Cl effect on uterine weight, relative to body weight, in percentages, for prepubertal female rats treated with 
control (H2Od, P.O.) or EEtOH-Cl (125, 250 and 500 mg/kg, P.O.) or estradiol (5 µg/kg, I.P.) or estradiol (5 µg/kg, I.P.) + 
tamoxifen (4 mg/kg, P.O.) or estradiol (5 µg/kg, I.P.) + EEtOH-Cl (125, 250 and 500 mg/kg, P.O.) or tamoxifen (4 mg/kg). 










The pre-implantation and post –implantation period and progeny 
were evaluated to study the toxicity during pregnancy. In these 
tests, we used 80 females divided into two equal groups. In the first 
group, we observed the evolution of pregnancy from day 1 to day 7 
(post –implantation); in the 2nd group, pregnancy from day 8 to day 
21(pregnancy), and the weaning period (21 days postnatal). The 
groups (n = 10) were treated daily per orally with EEtOH-Cl at 
doses of 125, 250 and 500 mg/kg and distilled water 1.0 mL/100 g 
(negative control = solvent extract). They received the extract daily 
at fixed times; however, in the second group, there was a pause in 
the administrations on the day of parturition, when the mother was 
placed in an isolated cage together with its offspring, and the 
administration continued until the date of weaning (day 21 of life). 
The females from the first group were euthanized on day 7 of the 
pregnancy, and those from the second group on the day of weaning 
their progeny. During pregnancy and lactation, we observed the 
following parameters: Weight gain, duration of pregnancy, birth 
rate, number of live births, and their viability. The progeny were 
observed twice a day for the following characteristics of evolution: 
the emergence of fur (5 to 7 days), bilateral eyelid opening (6 to 8 
days), displacement of the pinna (12 to 16 days), and opening of 
the vaginal canal in the female offspring (why about  35 days), in  
accordance to the study of Mello (2007). 
 
 
In vitro study 
 
In the in vitro study, we used uterine strips from 30 pregnant (P) 
and 30 non-pregnant females (NP) for isolated organ testing. The 
first group, comprising pregnant (n = 15) and non-pregnant animals 
(n = 15), received EEtOH-Cl (p.o.) at doses of 125, 250 and 500 
mg/kg for 13 days (treated - TT); and for the second group, the 
EEtOH-Cl was added directly to the vat containing uterine strips 
from pregnant (n = 15) and non-pregnant females (n = 15) (non-
treated - NT) at concentrations adjusted to 125, 250 and 500 µg/ml. 
The strips of uterus - removed, cleaned and devoid of any 
surrounding tissue - were suspended on cotton thread attached to a 
force transducer coupled to an acquisition system (AECAD 1604, 
AQCAD 2.0.5; AVS Projects, SP, Brazil) to record the isometric 
tensions. The strips were maintained in vats containing 10 ml Jalon 
solution at 32°C, under aeration with carbogenic mixture (95% O2 
and 5% CO2), and subjected to a tension of 1.0 g of load. 
Stabilization was carried out for 60 min, and the nutrient solution 
was replaced every 15 min to prevent interference of metabolites. 
The contractions were induced by KCl 80 mM and oxytocin for 





The results were presented as mean ± SEM and, in the in vivo 
stage, the data were subjected to analysis of variance by the 
program ANOVA (one-way), followed by the Bonferroni test. In the 
in vitro stage, the data were statistically analyzed by ANOVA (one-
way), followed by Tukey’s test. For the analysis of weights in the 
preimplantation period, we used Student’s t-test. For all stages, the 
level of statistical significance was 5% (p < 0.05). The construction  





Uterotrophic test  
 
The uterotrophic test results are expressed in Figure 1, It 
was observed that in the tests of estrogenicity, the rats 
treated with EEtOH-Cl at doses of 125, 250 and 500 
mg/kg and with estradiol alone developed a significant 
increase (p < 0.005) in relative weights of the uterus






Figure 2. Weight gain of progenitors exposed to EEtOH-Cl in the preimplantation period (1st to 7th day of pregnancy). The 
animals were treated with control (H2Od, P.O.) and EEtOH-Cl (125, 250 and 500 mg/kg, P.O.). Data expressed as mean ± SEM, 






Figure 3. Weight gain of progenitors exposed to EEtOH-Cl in the post-implantation period. The animals were 
treated with control (H2Od, P.O.) and EEtOH-Cl (125, 250 and 500 mg/kg, P.O.). Data expressed as mean ± 




(0.267 ± 0.016, 0.231 ± 0.014, 0.242 ± 0.015, 0.400 ± 
0.042, respectively), compared to the negative control 
group (0.086 ± 0.05), and were statistically similar (Figure 
1). 
In the anti-estrogenic treatments, the animals that received 
E + T (0.192 ± 0.021), E + EEtOH-Cl at doses  of 125, 
250 and 500 mg/kg (0.116 ± 0.006, 0.103 ± 0.06, 0.098 ± 
0.05, respectively) and tamoxifen alone (0.147 ± 0.020) 
showed a statistically significant reduction (p < 0.005) in 
uterine relative weights when compared with animals that 
received only estradiol (0.400 ± 0.042). 
Pre- and post-implantation tests and evaluation of the 
progeny 
 
We found that EEtOH-Cl did not alter the organ weights 
(liver, kidney, uterus and ovaries) in the control group. 
The weight gain of pregnant animals was not influenced 
by the extract, as shown in Figures 2 and 3 for the first 
group (1st to 7th day - preimplantation) and the 2nd 
group (8th to 21st day - post-implantation). 
The number of rat pups born and their viability showed 
no significant difference (p > 0.005) compared to the






Figure 4. Duration of pregnancy (in days) of progenitors exposed to EEtOH-Cl in the post-
implantation period. The animals were treated with control (H2Od, P.O.) and EEtOH-Cl (125, 250 
and 500 mg/kg, P.O.). Data expressed as mean ± SEM, n = 10. *p < 0.05 vs. control, one-way 






Figure 5. Contraction of the uterine wall (in tension), induced by KCl 80 mM in pregnant rats 





control, although, the duration of pregnancy was reduced 
at a dose of 125 mg/kg, as shown in Figure 4. The off-
spring descending from progenitors exposed to EEtOH-
Cl, at the three doses tested, did not exhibit changes in 
their weight gain or development, compared to the control 
group. 
 
In vitro tests of uterine contractility  
 
In vitro tests showed that for the uteri of pregnant females 
treated with EEtOH-Cl, at doses of 250 and 500 mg/kg, 
there was a statistically significant difference (p < 0.005) 
in inhibiting phasic contractions produced by KCl 80 mM, 
when compared with the control (Figure 5). Likewise, the 
uteri from non-pregnant females that were not treated 
with EEtOH-Cl at a concentration of 125 µg/mL had 
phasic contractions induced by oxytocin inhibited, which 
was statistically different from the control group (Figure 
6). Also, the uteri of pregnant females pretreated with 
EEtOH-Cl at a dose of 500 mg/kg of extract had inhibited 






Investigations on congenital malformations and on the 
toxicology tests predictive of foetal development are 
recent. Reproductive toxicity assessments generally com-
prise exposure of sexually mature animals before 
conception, during prenatal development, after birth and 
continuously until their sexual maturity (Mello, 2007). 
Estradiol, which is the predominant estrogen, is relea-
sed into systemic circulation and will work primarily in the 
alpha and beta estrogen receptors (ER) Importantly, epi-
thelial and stromal uterine cells express ER both early in 
development and in adult life, and therefore both tissues 
are susceptible to the effects of estrogens (Muller et al., 
2009; Brolio, 2010). In this study, the in vivo uterotrophic






Figure 6. Contraction of the uterine wall (in tension), induced by oxytocin in rats submitted to the following 







Figure 7. Contraction of the uterine wall (in tension), induced by oxytocin in isolated uterus of pregnant 




test was included in the design of the experimental 
protocol in order to assess the risk of toxicity. 
EEtOH-Cl increased the relative weight of the uterus in 
prepubertal rats, as well as the estradiol alone, inferring 
that the extract has estrogenic activity at the doses 
tested. However, the effect of estradiol was greater than 
that of EEtOH-Cl. Thus, considering that estrogenic 
actions are responsible for the production of the environ-
ment for fertilization, implantation, nutrition of the embryo 
and parturition, they are necessary for uterine cell 
development and tissue proliferation (Muller et al., 2009). 
The combination of the extract with estradiol showed a 
reduction of the relative weight of the uterus, just as the 
combination of estradiol with tamoxifen, suggesting anti-
estrogenic activity of the extract, and indicating that in 
this situation, it behaved similarly to tamoxifen, which is 
considered, primarily, an estrogenic antagonist acting to 
block the binding site of estrogen at the tissue receptor. It 
is important to remember that, depending on the orien-
tation of its side chain, tamoxifen can trigger anti-estro-
gen or estrogen because its activity seems to depend 
also on the state of the receptor, circulating levels, and 
target tissue (Ali et al., 2011). Therefore, the likely anti-
estrogenic activity of EEtOH-Cl is similar to the ambi-
guous behavior of tamoxifen, or the competition by the 
receptors reduced the activity of both estradiol and the 
extract. 
The appearance of embryofoetotoxic effects induced by 
various substances may result from their interaction with 
other factors that affect the mother-placenta-fetus as a 
whole, interfering in the nutritional state (Mello, 2007). 
Monitoring animal body weight is a strong indicator in 
assessing the toxicity of a substance (Silva et al., 2005). 
The situation of pregnancy involves weight gain because 
estrogen and progesterone influence food intake, energy 
consumption,  water  retention  rates  and  fat  deposition  




(Brolio, 2010). In this study, exposure of the progenitor to 
EEtOH-Cl during pre- and post-implantation did not alter 
the gain in body weight or the absolute and relative 
weights of the reproductive organs, that is, uterus and 
ovaries, or that of the non-reproductive organs such as 
the liver, kidneys and adrenal glands. There were also no 
macroscopic signs of toxicity observed in these organs. 
The evaluation of the absolute weights of the non-
reproductive organs is important, as the liver and kidneys 
are responsible for metabolism and elimination of xeno-
biotics and, in cases of intoxication, can have increased 
weight (Mello, 2007). 
Variations in gestation length, regarding its abbrevia-
tion, may be indicative of changes in biochemical pro-
cesses, since at the end of the pregnancy period estro-
gen levels rise and there is a decrease in progesterone 
levels. The estrogens initiate increased sensitivity of the 
myometrium to oxytocin through the induction of its 
receptors, and they also raise the production of prosta-
glandins (Wischral et al., 2001; Mello, 2007; Brolio, 
2010). Thus, a likely explanation for the reduced gesta-
tion time may be these possible estrogenic actions or the 
increased expression of estrogen receptors, and so, 
influence the structural characteristics of the cells of the 
myometrium to promote parturition, especially when 
exposed in late pregnancy (Muller et al., 2009). 
The uterine wall of mammals is comprised of smooth 
muscle in which calcium dependent mechanisms partici-
pate in the process of contraction (Travassos, 2010). This 
contraction, which is essential for foetal expulsion, 
involves complex events, which culminate with an in-
crease in intracellular [Ca
2+
], activation of myosin light 
chains, phosphorylation and, because of that, changing 
into chains of actin; however, all the mechanisms 
involved in uterine smooth muscle contraction are not yet 
fully understood (Du et al., 2006; Aguilar and Mitchel, 
2010). 
Observing the effect of EEtOH-Cl on contractions pro-
duced by KCl 80, we found that there was no significant 
inhibition or prolongation of these contractions in non-
pregnant, non-treated females (NP, NT) or in non-preg-
nant, treated females (NPT). Likewise, in pregnant, non-
treated females, there was no inhibition of contraction 
induced by KCl. However, in pregnant females treated 
with EEtOH-Cl, at doses of 250 and 500 mg/kg, there 
was significant inhibition of contraction induced by the 
contracting agent. Thereafter, it is possible to hypothe-
size that EEtOH-Cl can suppress expression of a recep-
tor or class of proteins involved in the contraction of the 
uterus. In this case, the gestation period is critical for this 
likely action, since in pregnancy there is participation of 
estradiol, prostaglandins, oxytocin, gap junctions and ion 
channels (Slater et al., 2002). It is known that estrogens 
stimulate the synthesis and formation of gap junctions 
between muscle cells, resulting in greater efficiency of 
the muscle action potential and synchronized contrac-





With respect to contractions induced by oxytocin in NP, 
NT females, we observed an inhibition of contraction at 
an EEtOH-Cl concentration of 125 µg/mL placed directly 
into the vat of the isolated organ. This fact suggests that 
EEtOH-Cl may have, in accordance with its estrogenic 
activity, sensitized receptors to its action. In this context, 
it is suggested that EEtOH-Cl can produce interference in 
labor, decreasing the threshold to stimulate uterine con-
tractility (Ramsey et al., 2011). 
In pregnant females treated (PT) with EEtOH-Cl  at a 
dose of 500 mg/kg, we observed inhibition of the phasic 
contractions induced by oxytocin, probably due to the 
influence of endogenous prostaglandins and oxytocin, 
characteristics of the end of pregnancy. 
Finally, we can infer that EEtOH-Cl does not seem to 
impede the achievement of the calcium-dependent 
events, which is common to both promoting agents of 
contraction (that is, KCl and oxytocin). While KCl 80 mM, 
through its depolarizing action, allows the influx of Ca
2+
 
into the interior of myometrial cells, oxytocin also does, 
upon binding to its receptors (Du et al., 2006; Chaves, 
2007). 
We conclude that EEtOH-Cl has estrogenic activity 
and, when combined with estradiol, presents anti-estro-
genic activity as well. It does not induce toxicity in pro-
genitors or in their offspring, and it inhibits isometric con-
tractions induced by KCl 80 mM and oxytocin in pregnant 
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